Experimental Design for Determination of Effects of Superdisintegrant Combinations on Liquisolid System Properties
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F17%3A43875603" target="_blank" >RIV/62157124:16370/17:43875603 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11160/17:10364244
Result on the web
<a href="http://dx.doi.org/10.1016/j.xphs.2016.11.002" target="_blank" >http://dx.doi.org/10.1016/j.xphs.2016.11.002</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.xphs.2016.11.002" target="_blank" >10.1016/j.xphs.2016.11.002</a>
Alternative languages
Result language
angličtina
Original language name
Experimental Design for Determination of Effects of Superdisintegrant Combinations on Liquisolid System Properties
Original language description
The preparation of liquisolid systems presents a promising and innovative possibility for enhancing dissolution profiles and improving the bioavailability of poorly soluble drugs. This study aims to evaluate the differences in the properties of liquisolid systems containing combinations of 3 commercially used superdisintegrants (sodium starch glycolate, crospovidone, and croscarmellose sodium). Multiple regression models and contour plots were used to study how the amount and the type of superdisintegrant used affected the quality parameters of liquisolid tablets. The results revealed that an increased amount of crospovidone in the mixture improves disintegration and wetting time and enhances drug release from the prepared liquisolid tablets. Moreover, it was observed that a binary blend of crospovidone and sodium starch glycolate improved tablet disintegration. Considering the obtained results, it could be stated that crospovidone showed the best properties to be used as superdisintegrant for the preparation of liquisolid systems containing rosuvastatin.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Pharmaceutical sciences
ISSN
0022-3549
e-ISSN
—
Volume of the periodical
106
Issue of the periodical within the volume
3
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
817-825
UT code for WoS article
000400398400016
EID of the result in the Scopus database
—